Skip to main content

From Rx Drug Abuse & Heroin Summit

Substance Use Disorder/Opioid Use Disorder

Robert Dupont, MD, discusses his session at the recent Rx Drug Abuse…
Karen Scott, MD, MPH, explains how the COVID‑19 pandemic affected access to treatment for opioid use disorder (OUD) and discusses policy changes that would allow maximum access to OUD treatment and…
Karen Scott, MD, MPH, President of the Foundation for Opioid Response Efforts, outlines barriers people face to receiving treatment for opioid use disorder, populations least likely to receive care…
Telehealth provides flexibility that addresses barriers to substance use disorder treatment, but more research on its efficacy is needed and providers want more training and technical assistance,…
Veterans Health Administration officials discuss opioid risk mitigation strategies, keys for aligning stakeholders in their mission, and changes made in light of the COVID-19 pandemic.
Officials from Massachusetts discuss the development of best practices for documentation and measurement to support post-overdose outreach programs, an increasingly popular concept across the U.S.
Allison Smith, PhD, senior program administrator for the Louisiana Board of Regents, discusses groups within college populations facing a heightened risk of opioid overdose, crafting policy around naloxone administration, and working with university leaders to make colleges safer.
Back to Top